173 related articles for article (PubMed ID: 12195351)
1. Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.
Daly KR; Fichtenbaum CJ; Tanaka R; Linke MJ; O'Bert R; Thullen TD; Hui MS; Smulian AG; Walzer PD
J Infect Dis; 2002 Sep; 186(5):644-51. PubMed ID: 12195351
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-linked immunosorbent assay and serologic responses to Pneumocystis jiroveci.
Daly KR; Koch J; Levin L; Walzer PD
Emerg Infect Dis; 2004 May; 10(5):848-54. PubMed ID: 15200818
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus-infected patients with prior Pneumocystis pneumonia exhibit increased serologic reactivity to several major surface glycoprotein clones.
Daly KR; Koch JV; Shire NJ; Levin L; Walzer PD
Clin Vaccine Immunol; 2006 Oct; 13(10):1071-8. PubMed ID: 17028210
[TBL] [Abstract][Full Text] [Related]
4. Serologic responses to recombinant Pneumocystis jirovecii major surface glycoprotein among Ugandan patients with respiratory symptoms.
Blount RJ; Jarlsberg LG; Daly KR; Worodria W; Davis JL; Cattamanchi A; Djawe K; Andama A; Koch J; Walzer PD; Huang L;
PLoS One; 2012; 7(12):e51545. PubMed ID: 23284710
[TBL] [Abstract][Full Text] [Related]
5. Direct correlation of genomic localization and surface expression of the major surface glycoprotein of Pneumocystis carinii.
Schaffzin JK; Stringer JR
J Eukaryot Microbiol; 1999; 46(5):127S. PubMed ID: 10519281
[No Abstract] [Full Text] [Related]
6. Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients.
Bishop LR; Kovacs JA
J Infect Dis; 2003 Jun; 187(12):1844-8. PubMed ID: 12792860
[TBL] [Abstract][Full Text] [Related]
7. Major surface glycoprotein genes from Pneumocystis carinii f. sp. ratti.
Schaffzin JK; Garbe TR; Stringer JR
Fungal Genet Biol; 1999 Dec; 28(3):214-26. PubMed ID: 10669586
[TBL] [Abstract][Full Text] [Related]
8. Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.
Gingo MR; Lucht L; Daly KR; Djawe K; Palella FJ; Abraham AG; Bream JH; Witt MD; Kingsley LA; Norris KA; Walzer PD; Morris A
J Acquir Immune Defic Syndr; 2011 Jul; 57(3):190-6. PubMed ID: 21372726
[TBL] [Abstract][Full Text] [Related]
9. Geographical variation in serological responses to recombinant Pneumocystis jirovecii major surface glycoprotein antigens.
Daly K; Koch J; Respaldiza N; de la Horra C; Montes-Cano MA; Medrano FJ; Varela JM; Calderon EJ; Walzer PD
Clin Microbiol Infect; 2009 Oct; 15(10):937-42. PubMed ID: 19416292
[TBL] [Abstract][Full Text] [Related]
10. Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.
Walzer PD; Djawe K; Levin L; Daly KR; Koch J; Kingsley L; Witt M; Golub ET; Bream JH; Taiwo B; Morris A
J Infect Dis; 2009 May; 199(9):1335-44. PubMed ID: 19301979
[TBL] [Abstract][Full Text] [Related]
11. Epitope study and cDNA screening of major surface glycoprotein of Pneumocystis carinii.
Nakamura Y; Kitada K; Wada M; Saito M
J Protozool; 1991; 38(6):3S-4S. PubMed ID: 1726327
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to Pneumocystis jirovecii major surface glycoprotein.
Daly KR; Huang L; Morris A; Koch J; Crothers K; Levin L; Eiser S; Satwah S; Zucchi P; Walzer PD
Emerg Infect Dis; 2006 Aug; 12(8):1231-7. PubMed ID: 16965702
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of novel variant major surface glycoprotein gene families in rat Pneumocystis carinii.
Huang SN; Angus CW; Turner RE; Sorial V; Kovacs JA
J Infect Dis; 1999 Jan; 179(1):192-200. PubMed ID: 9841839
[TBL] [Abstract][Full Text] [Related]
14. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region.
Mei Q; Turner RE; Sorial V; Klivington D; Angus CW; Kovacs JA
Infect Immun; 1998 Sep; 66(9):4268-73. PubMed ID: 9712777
[TBL] [Abstract][Full Text] [Related]
15. Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.
Djawe K; Daly KR; Vargas SL; Santolaya ME; Ponce CA; Bustamante R; Koch J; Levin L; Walzer PD
Int J Infect Dis; 2010 Dec; 14(12):e1060-6. PubMed ID: 20926326
[TBL] [Abstract][Full Text] [Related]
16. Humoral immune responses to Pneumocystis jirovecii antigens in HIV-infected and uninfected young children with pneumocystis pneumonia.
Djawe K; Daly KR; Levin L; Zar HJ; Walzer PD
PLoS One; 2013; 8(12):e82783. PubMed ID: 24386119
[TBL] [Abstract][Full Text] [Related]
17. Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients.
Wakefield AE; Lindley AR; Ambrose HE; Denis CM; Miller RF
J Infect Dis; 2003 Mar; 187(6):901-8. PubMed ID: 12660936
[TBL] [Abstract][Full Text] [Related]
18. Recombinant major surface glycoprotein of Pneumocystis carinii elicits a specific immune response but is not protective in immunosuppressed rats.
Lasbury ME; Angus CW; Klivington D; Durant PJ; Bartlett MS; Smith JW; Lee CH
J Eukaryot Microbiol; 1999; 46(5):136S-137S. PubMed ID: 10519289
[No Abstract] [Full Text] [Related]
19. Type-II major-surface-glycoprotein family of Pneumocystis carinii.
Wada M; Nakamura Y
J Eukaryot Microbiol; 1999; 46(5):125S-126S. PubMed ID: 10519280
[No Abstract] [Full Text] [Related]
20. Effects of clinical and environmental factors on bronchoalveolar antibody responses to Pneumocystis jirovecii: A prospective cohort study of HIV+ patients.
Blount RJ; Daly KR; Fong S; Chang E; Grieco K; Greene M; Stone S; Balmes J; Miller RF; Walzer PD; Huang L
PLoS One; 2017; 12(7):e0180212. PubMed ID: 28692651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
